Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis |
| |
Authors: | Frydrychowicz Alex Jedynak Andrzej R Kelcz Frederick Nagle Scott K Reeder Scott B |
| |
Affiliation: | Clinic for Radiology and Nucelar Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany; Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin, USA. |
| |
Abstract: |
Purpose: To investigate the value of gadoxetic acid‐enhanced three‐dimensional T1‐weighted MR cholangiography (T1w‐MRC) in comparison to three‐dimensional T2‐weighted MR cholangiopancreaticography (T2w‐MRCP) in patients with primary sclerosing cholangitis (PSC). Materials and Methods: Thirty‐four MR exams in 29 patients (46.0 ± 16.1 years; 19 men, 10 women) scanned within a 14‐month period were retrospectively included. Two abdominal radiologists independently evaluated image quality regarding image contrast, image quality degradation due to artifacts, and visualization quality of ducts. The order of biliary tree branches that were visualized and reader preference toward each method were recorded. Helpfulness of T1w‐MRC was scored in consensus. Confirmatory endoscopic retrograde cholangiopancreaticography (ERCP) performed within 3 months of the MR examination was available in 8 patients. Results: Image quality of T1w‐MRC and T2w‐MRCP was graded good to excellent in all cases. There were advantages for both T1w‐MRC (functional information, less degradation due to artifacts) and T2w‐MRCP (higher order of visualized branches, better branch depiction). Both readers showed preference for T2w‐MRCP; however, both readers found gadoxetic acid–enhanced T1w‐MRC helpful in the majority of cases. Conclusion: Gadoxetic acid‐enhanced T1w‐MRC is complementary to, but should not replace, T2w‐MRCP. T1w‐MRC is a useful adjunct to T2w‐MRCP for morphologic evaluation and provides additional diagnostic information. J. Magn. Reson. Imaging 2012;36:632–640. © 2012 Wiley Periodicals, Inc. |
| |
Keywords: | primary sclerosing cholangitis magnetic resonance cholangiography T1‐weighted MR cholangiography T2‐weighted MR cholangiopancreaticography gadoxetic acid hepatobiliary contrast enhancement |
本文献已被 PubMed 等数据库收录! |
|